Literature DB >> 22085358

Experimental autoimmune encephalomyelitis--achievements and prospective advances.

Helena Batoulis1, Mascha S Recks, Klaus Addicks, Stefanie Kuerten.   

Abstract

Multiple sclerosis (MS) is an autoimmune disorder of the CNS. Different subtypes of the disease have been noted, and characterized by distinct clinical courses and histopathologic manifestations. The most intensively studied animal model of MS, experimental autoimmune encephalomyelitis (EAE), classically leads to deficits in motor functions, and is mediated by T helper cells. Recently, T(H)17 cells were ascribed an even greater pathogenic impact than T(H)1 cells, but new findings render this view controversial. Although classic EAE has been an invaluable tool, it does not cover the entire pathogenic entity of MS. Especially B-cell contribution and autoantibody-dependence are not mirrored adequately: therefore, new B-cell-dependent models, such as MP4-induced EAE, have been introduced. Furthermore, certain symptoms and the spontaneous onset of MS are not featured in classic EAE. Herein, atypical and spontaneous EAE models can be used for investigation of common symptoms, such as tremor and ataxia, as well as spontaneous disease development. MS displays a marked inter-individual heterogeneity, and no single model will be able to cover all features. Thus, depending on the objective of one's study, the appropriate EAE model has to be carefully chosen. In addition, refined models should be designed to gain a more complete understanding of MS.
© 2011 The Authors. APMIS © 2011 APMIS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085358     DOI: 10.1111/j.1600-0463.2011.02794.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  27 in total

Review 1.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis.

Authors:  Nadine Hainz; Sandra Wolf; Thomas Tschernig; Carola Meier
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

3.  Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.

Authors:  Chan Chen; Yan-hua Li; Qiong Zhang; Jie-zhong Yu; Yong-fei Zhao; Cun-gen Ma; Bao-guo Xiao
Journal:  Acta Pharmacol Sin       Date:  2014-09-29       Impact factor: 6.150

4.  High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  B Oxombre; C Lee-Chang; A Duhamel; M Toussaint; M Giroux; M Donnier-Maréchal; P Carato; D Lefranc; H Zéphir; L Prin; P Melnyk; P Vermersch
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

5.  Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors.

Authors:  Hozefa S Bandukwala; John Gagnon; Susan Togher; Jason A Greenbaum; Edward D Lamperti; Nigel J Parr; Amy M H Molesworth; Nicholas Smithers; Kevin Lee; Jason Witherington; David F Tough; Rab K Prinjha; Bjoern Peters; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-21       Impact factor: 11.205

6.  Resveratrol (3, 5, 4'-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain.

Authors:  K Alexa Orr Gandy; Jiajia Zhang; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-02       Impact factor: 4.147

Review 7.  Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.

Authors:  Yudong Liu; Sara A Gibson; Etty N Benveniste; Hongwei Qin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

8.  Live imaging of targeted cell ablation in Xenopus: a new model to study demyelination and repair.

Authors:  Ferdinand Kaya; Abdelkrim Mannioui; Albert Chesneau; Sowmya Sekizar; Emmanuelle Maillard; Chantal Ballagny; Ludivine Houel-Renault; David Dupasquier; Odile Bronchain; Isabelle Holtzmann; Anne Desmazieres; Jean-Léon Thomas; Barbara A Demeneix; Peter J Brophy; Bernard Zalc; Andre Mazabraud
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

9.  ICAM-1: isoforms and phenotypes.

Authors:  Theresa N Ramos; Daniel C Bullard; Scott R Barnum
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

10.  2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.

Authors:  Gordon S Duncan; Dirk Brenner; Michael W Tusche; Anne Brüstle; Christiane B Knobbe; Andrew J Elia; Thomas Mock; Mark R Bray; Peter H Krammer; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.